Ken Griffin Cidara Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$0.64 - $0.92 $64 - $92	100 New	100 $0
Q3 2023 Nov 14, 2023	SELL	$0.77 - $1.16 $1,771 - $2,668	-2,300 Reduced 92.0%	200 $0
Q2 2023 Aug 14, 2023	SELL	$1.01 - $1.42 $32,623 - $45,866	-32,300 Reduced 92.82%	2,500 $2,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.98 $26,100 - $68,904	34,800 New	34,800 $44,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.